Jane Diggle qualified with a BSc (Hons) in Nursing in 1990 (Leeds) and has over 20 years’ experience working as a practice nurse. Over the past three years, she has specialised solely in diabetes but still within a general practice setting. She is an independent prescriber and has gained MSc modules in Insulin Management and New & Advanced Therapies from Leicester University. She is the former Co-Vice-Chair of the Primary Care Diabetes Society in 2016 and has been part of the committee since 2010. She is the Editor-in-Chief for Diabetes and Primary Care Journal and regularly publishes articles on practical aspects of diabetes care. Additionally, Jane regularly speaks at national conferences on various aspects of diabetes management.
Alex Miras is Professor of Endocrinology at Ulster University. His clinical and research work focus solely on obesity and type 2 diabetes. He has contributed to clinical management policy and research in the field of obesity over the last 14 years. The specialist interests of his research group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices, and obesity surgery. Professor Miras is a member of the National Institute for Health and Care Excellence (NICE) obesity management guidelines committee, trustee of the Association for the Study of Obesity and Chair of the research subcommittee of the National Bariatric Surgery Registry. He is associate editor for the journals Obesity and Surgery for Obesity and Related Diseases (SOARD).
Eveleigh Nicholson has been a Consultant in Diabetes and Endocrinology in Portsmouth since 2016. She has a specialist interest in obesity and bariatric medicine, working within the Portsmouth City tier 3 programme and in one of the largest surgical bariatric centres in Queen Alexandra Hospital as the specialist physician.
Additionally, Dr Nicholson is Director of Undergraduate Medical Education at Portsmouth Hospitals NHS Trust and Co-Director of the Southern Diabetes Medical Services Llp.
Roy Taylor qualified in medicine at the University of Edinburgh, and is Professor of Medicine at Newcastle University. He founded the Newcastle Magnetic Resonance Centre in 2006 to develop innovative research techniques. Using these methods, he showed that his 2008 Twin Cycle Hypothesis could be proven in clinical practice. Type 2 diabetes was shown to be a simple, reversible condition of excess fat within the liver and pancreas. Subsequently, he has extended these observations on the cause of type 2 diabetes and how remission can be achieved. This has led to practical application in the National Health Service with the national ‘NHS Type 2 Diabetes Path to Remission’ programme, which is now successfully in place.
Between 1986 and 2000, Professor Taylor developed the system now used throughout the United Kingdom for screening for diabetic eye disease, aiding the major reduction in blindness due to diabetes across the UK.
He has published books in lay language explaining type 2 diabetes (e.g., ‘Life Without Diabetes’) plus training books on retinal screening. He has been invited to deliver named lectures, including the 2012 Banting Lecture of Diabetes UK and the 2024 Claude Bernard Lecture of the European Association for the Study of Diabetes (EASD). He received the 2023 Robert Turner Award for Research Impact. Professor Taylor was made MBE in the King’s 2023 New Year Honours list.
Adverse events and product complaints should be reported. Reporting forms and information can be found at: www.mhra.gov.uk/yellowcard or search MHRA Yellow Card in the Google Play or Apple App Store. Adverse events and product complaints should also be reported to Lilly: please call Lilly on 01256 315 000.
PP-LD-GB-2573 | November 2024
The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions. Copyright OmniaMed Communications Ltd®. Any distribution or duplication of the information contained herein is strictly prohibited. Omniamedcommunications.com may store small data files on your computer called cookies so that we can recognise you and provide you with the best service. If you do not want to receive cookies please do not use omniamedcommunications.com.
To continue, please confirm that you are a GB healthcare professional by clicking one of the buttons below.